Plantar Fasciitis
Conditions
Keywords
plantar fasciitis, multisegment foot motion, gait, physical therapy, strengthening, stretching, exercise, translation, plantar heel pain
Brief summary
Plantar fasciitis (PF) is a prevalent musculoskeletal condition of plantar heel pain (PHP) that leads to pain, functional limitations, and reduced quality of life, especially among active adults aged 25 to 65. Understanding the biomechanical alterations in foot motion among individuals with PF is essential to inform targeted treatment strategies and prevent symptom chronicity. However, research exploring detailed multi-segment foot motion changes in this population remains limited. Assessing foot function is a key component in understanding symptom development and treatment outcomes. The Foot Function Index (FFI) is an internationally recognized, reliable, and valid questionnaire used to measure foot pain and disability. To facilitate its use in Thai populations and enable cross-cultural comparisons, it is crucial to translate and validate the FFI into Thai. Although exercise interventions such as strengthening and stretching are widely used to manage PHP, evidence regarding their relative effectiveness on pain reduction and gait improvement is inconclusive. Rigorous evaluation of these programs is needed to establish evidence-based guidelines for physical therapy in this population. Study 1: Comparative Study of Gait and Foot Segment Motion Between Individuals with Plantar Fasciitis and Healthy Controls This study aimed to compare multi-segment foot motion during walking between individuals with plantar fasciitis (PF) and healthy controls. A matched case-control design was used, with gait data collected via a 3D motion capture system and analyzed using the Oxford Foot Model. Study 2: Translation and Validation of the Thai Version of the Foot Function Index (FFI-Th) This study aimed to translate the Foot Function Index (FFI) into Thai (FFI-Th) and evaluate its psychometric properties individuals with plantar foot complaints. Study 3: Effects of Strengthening and Stretching Exercise Programs on Pain and Gait in Patients with Plantar Fasciitis: A Randomized Controlled Trial This study aimed to investigate the effects of physical therapy interventions-specifically strengthening versus stretching exercise programs-on pain and temporospatial gait parameters in patients with PF.
Detailed description
Procedure Study 1: Comparative Study of Gait and Foot Segment Motion Between Individuals with Plantar Fasciitis and Healthy Controls A matched case-control study recruited individuals with PF and matched healthy controls by age, gender, weight, and height. After informed consent, anthropometric data were collected, and participants wore tight clothing to allow accurate marker placement. Forty-two reflective markers were attached to define foot and lower limb segments following the Oxford Foot Model and Plug-In-Gait protocols. A static calibration trial was recorded, after which some markers were removed. Then, participants performed walking trials along an 8-meter walkway while motion capture cameras and force plates recorded kinematic and kinetic data simultaneously. Each participant completed 3-5 gait trials at a self-selected comfortable speed, with two trials matching the control group's gait speed and cadence selected for analysis. Data were filtered and normalized over the gait cycle for further assessment. Outcome measures included ground reaction forces (GRFs) during braking and propulsion phases and peak multi-segment foot joint angles in three planes. Study 2: Translation and Validation of the Thai Version of the Foot Function Index (FFI-Th) This study used a cross-sectional design to translate and validate the Foot Function Index (FFI) into Thai (FFI-Th) following a standardized cross-cultural adaptation process. The steps included independent forward translation by two bilingual translators, synthesis by an expert committee, backward translation by two native English speakers, harmonization through consensus meetings, cognitive interviews with 20 individuals to ensure clarity, and final proofreading by a linguist. To assess criterion validity, participants also completed the EuroQol five-dimensional questionnaire (EQ-5D-5L) for health-related quality of life and a pain visual analogue scale (pain-VAS). These instruments provided comparative data for evaluating the FFI-Th's validity. Study 3; Effects of Strengthening and Stretching Exercise Programs on Pain and Gait in individuals with Plantar Fasciitis: A Randomized Controlled Trial This double-blind, randomized controlled trial was used. Individuals with PF were screened and recruited based on specific inclusion and exclusion criteria. After obtaining informed consent, participants were randomly assigned into two groups: strengthening exercises or stretching exercises. All participants received a standardized physical therapy treatment including therapeutic ultrasound and manual therapy, followed by their assigned exercise programs instructed by blinded physical therapists. Participants performed home-based exercises three times daily for 4 weeks, then continued at home for 2 months with exercise logs to monitor compliance. Outcome assessments were conducted five times: baseline, mid-intervention, post-intervention, and at 1- and 2-month follow-ups. Data collected included demographics, pain intensity via visual analogue scale (VAS), and temporospatial gait parameters measured by a force distribution platform and synchronized video system.
Interventions
Conservative physical therapy treatment with home-based strengthening exercises (study 3)
Conservative physical therapy treatment with home-based stretching exercises (study 3)
Sponsors
Study design
Masking description
Conservative physical therapy intervention was launched by the same physical therapist who blind to participant group allocation.
Intervention model description
A stratified randomization table according to age (less or more than 50 years) and pain score (less or more than 5 out of 10 scores) was used.
Eligibility
Inclusion criteria
Study 1: Comparative Study of Gait and Foot Segment Motion Between Individuals with Plantar Fasciitis and Healthy Controls Inclusion Criteria (PF Group): * Aged 20-80 years * Plantar fasciitis (PF) symptoms for at least one month * Pain or tenderness at the medial calcaneal tubercle or proximal plantar fascia * At least one of the following symptoms: * Morning pain (first steps in the morning) * Pain after prolonged sitting * Pain during weight-bearing activities
Exclusion criteria
(PF Group): * Other painful conditions in the lower extremity or back * History of rheumatoid arthritis * Neurological or vascular diseases * Leg length discrepancy \>1 cm * Severe pain preventing walking Inclusion Criteria (Healthy Controls): * No current or previous history of PF symptoms * No foot pain
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Worst Pain | Baseline, 2 weeks after the intervention, 4 weeks after the intervention, 1-month follow-up, and 2-month follow-up | Worst pain was assessed using the Visual analog scale (VAS), where 0 indicates no pain and 10 indicates pain as bad as participants can imagine. Participants were asked to report their worst pain level over the past 24 hours. Higher scores indicate more severe pain. Unit of Measure: scores |
| Morning Pain | Baseline, 2 weeks after the intervention, 4 weeks after the intervention, 1-month follow-up, and 2-month follow-up | Morning pain intensity upon waking was assessed using a 10 cm Visual Analog Scale (VAS), where participants mark a point along a continuous line anchored by no pain (0) and worst imaginable pain (10), with higher values indicating more severe morning pain. Unit of Measure: scores |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Cadence | Baseline, 2 weeks after the intervention, 4 weeks after the intervention, 1-month follow-up, and 2-month follow-up | Cadence refers to the number of steps taken per minute during walking. It is a critical parameter in gait analysis, influencing both performance and injury risk, and the effectiveness of rehabilitation programs. Unit of Measure: steps/minute |
| Stride Length | Baseline, 2 weeks after the intervention, 4 weeks after the intervention, 1-month follow-up, and 2-month follow-up | Stride length is the distance covered between two consecutive placements of the same foot during walking. It represents the length of a full gait cycle, encompassing both the stance and swing phases of the same limb. In clinical assessments, stride length is measured to evaluate gait efficiency, balance, and the effectiveness of rehabilitation program. Unit of Measure: meter |
| Stride Time | Baseline, 2 weeks after the intervention, 4 weeks after the intervention, 1-month follow-up, and 2-month follow-up | Time spend during walking over one gait cycle (s) Stride time refers to the duration of one full gait cycle, measured from the initial contact of one foot to the subsequent initial contact of the same foot. It encompasses both the stance and swing phases of the limb's movement. Stride time is a critical temporal parameter in gait analysis, providing insights into the rhythm and coordination of walking. Unit of Measure: second |
| Gait Speed | Baseline, 2 weeks after the intervention, 4 weeks after the intervention, 1-month follow-up, and 2-month follow-up | Distance of walking over time (m/s) Gait speed refers to the rate at which an individual walks. It serves as a crucial indicator of mobility and overall physical fitness, playing a significant role in assessing an individual's balance, endurance, and functional abilities. Unit of Measure: meter/second |
Countries
Thailand
Participant flow
Recruitment details
Conducted at Physical Therapy Center, Mahidol University (study 3)
Participants by arm
| Arm | Count |
|---|---|
| Strengthening Group Conservative physical therapy with home-based strengthening exercises | 42 |
| Stretching Group Conservative physical therapy with home-based stretching exercises | 42 |
| Total | 84 |
Baseline characteristics
| Characteristic | Stretching Group | Total | Strengthening Group |
|---|---|---|---|
| Age, Continuous | 52.86 years STANDARD_DEVIATION 9.84 | 52.40 years STANDARD_DEVIATION 9.97 | 51.95 years STANDARD_DEVIATION 10.1 |
| Height | 159.45 cm STANDARD_DEVIATION 8.13 | 160.05 cm STANDARD_DEVIATION 8.67 | 161.13 cm STANDARD_DEVIATION 9.18 |
| Pain at worst intensity | 5.74 scores STANDARD_DEVIATION 2.3 | 5.85 scores STANDARD_DEVIATION 2.3 | 5.96 scores STANDARD_DEVIATION 2.3 |
| Race and Ethnicity Not Collected | — | 0 Participants | — |
| Sex: Female, Male Female | 33 Participants | 62 Participants | 29 Participants |
| Sex: Female, Male Male | 9 Participants | 22 Participants | 13 Participants |
| Weight | 65.14 kg STANDARD_DEVIATION 12.52 | 65.40 kg STANDARD_DEVIATION 11.9 | 65.66 kg STANDARD_DEVIATION 11.26 |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk |
|---|---|---|
| deaths Total, all-cause mortality | 0 / 42 | 0 / 42 |
| other Total, other adverse events | 0 / 42 | 0 / 42 |
| serious Total, serious adverse events | 0 / 42 | 0 / 42 |
Outcome results
Morning Pain
Morning pain intensity upon waking was assessed using a 10 cm Visual Analog Scale (VAS), where participants mark a point along a continuous line anchored by no pain (0) and worst imaginable pain (10), with higher values indicating more severe morning pain. Unit of Measure: scores
Time frame: Baseline, 2 weeks after the intervention, 4 weeks after the intervention, 1-month follow-up, and 2-month follow-up
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Strengthening Group | Morning Pain | 2 weeks after the intervention | 3.70 score | Standard Deviation 2.28 |
| Strengthening Group | Morning Pain | 1-month follow-up | 2.25 score | Standard Deviation 2.51 |
| Strengthening Group | Morning Pain | 4 weeks after the intervention | 2.90 score | Standard Deviation 2.46 |
| Strengthening Group | Morning Pain | 2-month follow-up | 1.30 score | Standard Deviation 1.54 |
| Strengthening Group | Morning Pain | Baseline | 5.86 score | Standard Deviation 2.51 |
| Stretching Group | Morning Pain | 2-month follow-up | 1.52 score | Standard Deviation 2.12 |
| Stretching Group | Morning Pain | Baseline | 5.04 score | Standard Deviation 2.35 |
| Stretching Group | Morning Pain | 2 weeks after the intervention | 3.63 score | Standard Deviation 2.54 |
| Stretching Group | Morning Pain | 4 weeks after the intervention | 2.75 score | Standard Deviation 2.52 |
| Stretching Group | Morning Pain | 1-month follow-up | 1.98 score | Standard Deviation 2.24 |
Worst Pain
Worst pain was assessed using the Visual analog scale (VAS), where 0 indicates no pain and 10 indicates pain as bad as participants can imagine. Participants were asked to report their worst pain level over the past 24 hours. Higher scores indicate more severe pain. Unit of Measure: scores
Time frame: Baseline, 2 weeks after the intervention, 4 weeks after the intervention, 1-month follow-up, and 2-month follow-up
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Strengthening Group | Worst Pain | 2 weeks after the intervention | 3.91 score | Standard Deviation 2.38 |
| Strengthening Group | Worst Pain | 1-month follow-up | 2.52 score | Standard Deviation 2.55 |
| Strengthening Group | Worst Pain | 4 weeks after the intervention | 3.09 score | Standard Deviation 2.25 |
| Strengthening Group | Worst Pain | 2-month follow-up | 1.73 score | Standard Deviation 2.16 |
| Strengthening Group | Worst Pain | Baseline | 5.96 score | Standard Deviation 2.3 |
| Stretching Group | Worst Pain | 2-month follow-up | 2.69 score | Standard Deviation 2.55 |
| Stretching Group | Worst Pain | Baseline | 5.74 score | Standard Deviation 2.3 |
| Stretching Group | Worst Pain | 2 weeks after the intervention | 4.08 score | Standard Deviation 2.29 |
| Stretching Group | Worst Pain | 4 weeks after the intervention | 3.34 score | Standard Deviation 2.47 |
| Stretching Group | Worst Pain | 1-month follow-up | 2.69 score | Standard Deviation 2.55 |
Cadence
Cadence refers to the number of steps taken per minute during walking. It is a critical parameter in gait analysis, influencing both performance and injury risk, and the effectiveness of rehabilitation programs. Unit of Measure: steps/minute
Time frame: Baseline, 2 weeks after the intervention, 4 weeks after the intervention, 1-month follow-up, and 2-month follow-up
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Strengthening Group | Cadence | Baseline | 103.16 steps/minute | Standard Deviation 7.75 |
| Strengthening Group | Cadence | 4 weeks after the intervention | 104.03 steps/minute | Standard Deviation 8.42 |
| Strengthening Group | Cadence | 2-month follow-up | 105.50 steps/minute | Standard Deviation 8.47 |
| Strengthening Group | Cadence | 1-month follow-up | 104.72 steps/minute | Standard Deviation 8.45 |
| Strengthening Group | Cadence | 2 weeks after the intervention | 102.85 steps/minute | Standard Deviation 8.54 |
| Stretching Group | Cadence | 2-month follow-up | 104.81 steps/minute | Standard Deviation 9.49 |
| Stretching Group | Cadence | Baseline | 101.37 steps/minute | Standard Deviation 10.44 |
| Stretching Group | Cadence | 2 weeks after the intervention | 103.70 steps/minute | Standard Deviation 9.82 |
| Stretching Group | Cadence | 4 weeks after the intervention | 103.46 steps/minute | Standard Deviation 10.42 |
| Stretching Group | Cadence | 1-month follow-up | 104.16 steps/minute | Standard Deviation 9.35 |
Gait Speed
Distance of walking over time (m/s) Gait speed refers to the rate at which an individual walks. It serves as a crucial indicator of mobility and overall physical fitness, playing a significant role in assessing an individual's balance, endurance, and functional abilities. Unit of Measure: meter/second
Time frame: Baseline, 2 weeks after the intervention, 4 weeks after the intervention, 1-month follow-up, and 2-month follow-up
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Strengthening Group | Gait Speed | 2-month follow-up | 0.94 meter/second | Standard Deviation 0.12 |
| Strengthening Group | Gait Speed | Baseline | 0.90 meter/second | Standard Deviation 0.11 |
| Strengthening Group | Gait Speed | 2 weeks after the intervention | 0.91 meter/second | Standard Deviation 0.12 |
| Strengthening Group | Gait Speed | 4 weeks after the intervention | 0.92 meter/second | Standard Deviation 0.12 |
| Strengthening Group | Gait Speed | 1-month follow-up | 0.93 meter/second | Standard Deviation 0.12 |
| Stretching Group | Gait Speed | 1-month follow-up | 0.93 meter/second | Standard Deviation 0.13 |
| Stretching Group | Gait Speed | 4 weeks after the intervention | 0.91 meter/second | Standard Deviation 0.13 |
| Stretching Group | Gait Speed | Baseline | 0.87 meter/second | Standard Deviation 0.13 |
| Stretching Group | Gait Speed | 2-month follow-up | 0.94 meter/second | Standard Deviation 0.13 |
| Stretching Group | Gait Speed | 2 weeks after the intervention | 0.91 meter/second | Standard Deviation 0.13 |
Stride Length
Stride length is the distance covered between two consecutive placements of the same foot during walking. It represents the length of a full gait cycle, encompassing both the stance and swing phases of the same limb. In clinical assessments, stride length is measured to evaluate gait efficiency, balance, and the effectiveness of rehabilitation program. Unit of Measure: meter
Time frame: Baseline, 2 weeks after the intervention, 4 weeks after the intervention, 1-month follow-up, and 2-month follow-up
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Strengthening Group | Stride Length | Baseline | 1.05 meter | Standard Deviation 0.11 |
| Strengthening Group | Stride Length | 1-month follow-up | 1.07 meter | Standard Deviation 0.09 |
| Strengthening Group | Stride Length | 4 weeks after the intervention | 1.05 meter | Standard Deviation 0.1 |
| Strengthening Group | Stride Length | 2-month follow-up | 1.07 meter | Standard Deviation 0.1 |
| Strengthening Group | Stride Length | 2 weeks after the intervention | 1.06 meter | Standard Deviation 0.1 |
| Stretching Group | Stride Length | 2-month follow-up | 1.08 meter | Standard Deviation 0.1 |
| Stretching Group | Stride Length | 2 weeks after the intervention | 1.06 meter | Standard Deviation 0.1 |
| Stretching Group | Stride Length | 4 weeks after the intervention | 1.05 meter | Standard Deviation 0.1 |
| Stretching Group | Stride Length | 1-month follow-up | 1.07 meter | Standard Deviation 0.11 |
| Stretching Group | Stride Length | Baseline | 1.03 meter | Standard Deviation 0.1 |
Stride Time
Time spend during walking over one gait cycle (s) Stride time refers to the duration of one full gait cycle, measured from the initial contact of one foot to the subsequent initial contact of the same foot. It encompasses both the stance and swing phases of the limb's movement. Stride time is a critical temporal parameter in gait analysis, providing insights into the rhythm and coordination of walking. Unit of Measure: second
Time frame: Baseline, 2 weeks after the intervention, 4 weeks after the intervention, 1-month follow-up, and 2-month follow-up
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Strengthening Group | Stride Time | 4 weeks after the intervention | 1.15 second | Standard Deviation 0.1 |
| Strengthening Group | Stride Time | 1-month follow-up | 1.15 second | Standard Deviation 0.1 |
| Strengthening Group | Stride Time | 2-month follow-up | 1.14 second | Standard Deviation 0.1 |
| Strengthening Group | Stride Time | Baseline | 1.17 second | Standard Deviation 0.09 |
| Strengthening Group | Stride Time | 2 weeks after the intervention | 1.17 second | Standard Deviation 0.1 |
| Stretching Group | Stride Time | 2 weeks after the intervention | 1.16 second | Standard Deviation 0.12 |
| Stretching Group | Stride Time | 4 weeks after the intervention | 1.17 second | Standard Deviation 0.13 |
| Stretching Group | Stride Time | Baseline | 1.19 second | Standard Deviation 0.13 |
| Stretching Group | Stride Time | 1-month follow-up | 1.16 second | Standard Deviation 0.11 |
| Stretching Group | Stride Time | 2-month follow-up | 1.15 second | Standard Deviation 0.11 |